Browsing Tag
University of Pennsylvania
9 posts
AACR Annual Meeting 2026: what cancer researchers and pharma professionals need to know before San Diego
AACR Annual Meeting 2026 runs April 17-22 at San Diego Convention Center. Over 7,400 abstracts, six plenaries, AI, CAR T, ADCs and RAS inhibitor data.
Can Nia’s 60-channel brain implant redefine closed-loop neuromodulation in memory therapy?
Nia Therapeutics validates its wireless brain implant for closed-loop memory stimulation. Find out how it could transform treatment for traumatic brain injury.
Children’s Hospital of Philadelphia study uncovers missing RNA fragments as potential key to targeted immunotherapy for pediatric brain tumors
CHOP researchers discover that missing RNA microexons in pediatric brain tumors create a targetable NRCAM variant, opening new paths for safer immunotherapy.
Star Cat and Sun Bear debuts new sci-fi franchise with digital release of Talisman of Doom
Star Cat and Sun Bear launches with Talisman of Doom and new universe hub. A bold new sci-fi IP enters the market. Explore the digital edition today.
Cell therapy in solid tumors: Breakthroughs, delivery challenges, and what’s next
Discover how new trials and biotech innovations are tackling the biggest hurdles in adapting cell therapy for solid tumors. See what’s changing now.
Chimeric Therapeutics secures new funding boost as cancer cell therapy trials accelerate
Discover how Chimeric Therapeutics' A$1M entitlement offer will drive innovation across CAR-T and NK cell therapy programs. Read the full story here.
Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial
Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute…
Penn in disarray: President Magill’s resignation sparks heated debate and investigation
In a dramatic turn of events, University of Pennsylvania President Elizabeth Magill has announced her resignation, following intense…
Gilead’s Kite to acquire CAR T-therapies developer Tmunity Therapeutics
Kite, an arm of Gilead Sciences, has agreed to acquire Tmunity Therapeutics, a Philadelphia-based clinical-stage biotech company focused…